Moreover, identification of miRNAs involved in CD8+ T cell cytotoxic activity could lead to develop efficient approaches for HIV control by ex vivo modified T cells, analogously to tumour control by CART cells or NK cells therapies. The gene discussed is CD8A; the disease is neoplasm.